REPORT RELEASE (DIGITAL): Q4 2027
Oncology Innovation Report Europe 2027
Highlighting the Ecosystems, Stakeholders and Initiatives Transforming Cancer Care Across Europe.
Discover the companies, research institutions, healthcare organisations, technologies, and innovation ecosystems driving progress in oncology across Europe.
About the Report
Europe is home to a diverse and dynamic oncology innovation ecosystem, bringing together leading research institutions, healthcare organisations, innovative companies, investors, and public initiatives shaping the future of cancer care.
The European Oncology Innovation Report 2027 is an independent publication dedicated to highlighting, showcasing, and connecting this ecosystem. It provides an overview of the most visible, active and prominent organisations, stakeholders, technologies, and initiatives driving and supporting oncology innovation across Europe.
The report covers startups, scaleups, pharmaceutical and biotech companies, hospitals, research institutions, investors, and innovation hubs, while placing particular emphasis on European institutions, regulatory bodies, funding programmes, and strategic initiatives such as the EU Mission on Cancer and Europe’s Beating Cancer Plan.
Our mission is to increase the international visibility of European oncology innovation, highlight key players and initiatives, and foster collaboration, investment, and knowledge exchange across the European cancer innovation landscape.
Scope & Key Areas
The European Oncology Innovation Report 2027 highlights the key organisations, stakeholders, initiatives, technologies, and developments driving and supporting oncology innovation across Europe.
European Oncology Stakeholders, Institutions & Initiatives
Highlighting European institutions, regulatory bodies, public programmes, funding initiatives, and collaborative networks supporting oncology innovation, including the EU Mission on Cancer, EMA, and Europe’s Beating Cancer Plan.
Startups, Scaleups & University Spin-offs
Emerging companies developing innovative products, technologies, diagnostics, therapeutics, and services across the oncology value chain.
Pharmaceutical & Biotechnology Innovation
Companies advancing drug discovery, targeted therapies, immunotherapy, precision medicine, and next-generation cancer treatments.
Research & Clinical Innovation
Universities, research institutions, cancer centers, and clinical research networks advancing scientific discovery and clinical practice.
Digital Health, AI & Medical Technology
Innovations in artificial intelligence, diagnostics, medical imaging, digital health, and medical devices.
Hospitals & Healthcare Innovation
Hospitals, specialised cancer centers, and healthcare organisations advancing cancer prevention, diagnosis, treatment, and patient care.
Investment & Funding Ecosystem
Investors, venture capital firms, business angels, and funding organisations supporting oncology innovation.
Innovation Hubs & Ecosystem Supporters
Clusters, incubators, accelerators, technology transfer offices, foundations, and organisations fostering collaboration and innovation across Europe.
Get Involved
Help us map, showcase, and connect Europe’s oncology innovation ecosystem. Whether you are developing innovative solutions, supporting oncology innovation, or looking to become a strategic partner, there are several ways to participate.
FOR INNOVATORS
Are you developing an oncology innovation?
Are you a startup, scaleup, spin-off, or company developing innovative products, technologies, diagnostics, or therapies in oncology? Submit your organisation’s information to be considered for inclusion in the European Oncology Innovation Mapping.
FOR ECOSYSTEM STAKEHOLDERS
Are you supporting oncology innovation in Europe?
We welcome European institutions, research organisations, hospitals, cancer networks, clusters, investors, initiatives, associations, and other ecosystem stakeholders. Share your organisation’s information to be considered for inclusion in our European Oncology Innovation Mapping.
FOR SPONSORS & PARTNERS
Get Your Spotlight
Highlight your company in the European Oncology Innovation Report 2027. Position your organisation within Europe’s oncology innovation ecosystem and gain visibility among an international audience of healthcare leaders, innovators, researchers, investors, and policymakers.
Format & Distribution
Format
Independent report (~40–50 pages, A4)
Language
English
Availability
Digital in PDF (Print optional)
Distribution period
2027–2028
Report release (digital)
Q4 2027
DISTRIBUTION & OUTREACH
The report will be distributed through a targeted European and international outreach strategy, reaching key decision-makers, institutions, and stakeholders across the oncology ecosystem. Distribution activities will include:
- European Institutions & EU Bodies: Presentation and dissemination to relevant European institutions, EU agencies, and organisations.
- Strategic Partnerships: Collaboration with European and international healthcare, oncology, and innovation networks.
- Direct Outreach: Distribution to hospitals, cancer centers, universities, research institutions, pharma, biotech, and medtech companies.
- Industry Networks: Engagement with associations, clusters, innovation hubs, NGOs, and professional networks.
- Media & Digital Channels: Collaboration with specialised media and distribution through websites, newsletters, and social media.
- Conferences & Events: Presentation and promotion at selected European and international industry events.
- Investors & Corporate Networks: Outreach to investors, venture capital firms, and corporate innovation leaders.
Target Audience
The publication is designed for stakeholders across the European and international oncology innovation ecosystem.
Pharmaceutical, Biotechnology & Healthcare Companies
Hospitals, Clinics & Cancer Centers
Oncologists & Medical Professionals
Policymakers & Healthcare Administrators
European Institutions & Innovation Clusters
Investors, Venture Capital & Business Angels
Startups, Scaleups & University Spin-offs
Academic & Research Institutions
Innovation Hubs & Ecosystem Supporters
Support the Initiative
Join us in showcasing and strengthening Europe’s oncology innovation ecosystem. As a partner of the European Oncology Innovation Report 2027, your organisation will gain visibility among a targeted international audience of healthcare leaders, pharmaceutical companies, investors, researchers, innovators, and policymakers.
The report offers an opportunity to position your organisation at the forefront of oncology innovation, demonstrate your commitment to advancing cancer care, and connect with relevant stakeholders across the European healthcare and life sciences landscape.
Together, we can increase the visibility of European innovation, strengthen cross-border collaboration, support emerging companies, and accelerate the development and adoption of solutions that improve the lives of people affected by cancer.
Become a partner and help shape the future of oncology innovation in Europe.